Valuation: PROCEPT BioRobotics Corporation

Market Cap 1.1B 985M 906M 821M 1.53B 104B 1.56B 10.8B 4.34B 54.92B 4.13B 4.04B 173B P/E 2026 *
-11.6x
P/E 2027 * -17.5x
Enterprise Value 974M 872M 802M 727M 1.36B 92.45B 1.38B 9.57B 3.84B 48.63B 3.65B 3.58B 153B EV / Sales 2026 *
2.46x
EV / Sales 2027 * 2.05x
Free-Float
96.51%
Yield 2026 *
-
Yield 2027 * -
1 day-5.42%
1 week-3.81%
1 month+5.38%
3 months+3.11%
6 months-20.13%
Current year-38.97%
1 week 18.9
Extreme 18.9
20.67
1 month 16.95
Extreme 16.95
20.67
Current year 16.66
Extreme 16.665
35.4
1 year 16.66
Extreme 16.665
38.11
3 years 16.66
Extreme 16.665
103.81
5 years 15.38
Extreme 15.38
103.81
10 years 15.38
Extreme 15.38
103.81
Manager TitleAgeSince
Chief Executive Officer 60 01/09/2025
Director of Finance/CFO 48 30/09/2018
Chief Operating Officer 56 28/02/2026
Director TitleAgeSince
Chairman 74 28/02/2021
Director/Board Member 48 31/05/2015
Director/Board Member 50 30/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Free

Director

19,918 0.0348%
09/09/26 Sell

Chief Technology Officer

-373 0.0007%
09/09/26 Sell

General Counsel

-297 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-5.42%-3.81%-43.58%-28.33% 1.1B
+1.56%+2.41%-14.09%+12.32% 184B
-0.59%+1.18%+6.44%+36.82% 118B
-6.38%-4.98%-18.07%+8.01% 112B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -1.17%-0.33%-11.17%+20.58% 76.04B
Weighted average by Cap. -0.50%+0.23%-10.19%+23.66%

Financials

2026 *2027 *
Net sales 395M 354M 326M 295M 552M 37.53B 562M 3.88B 1.56B 19.74B 1.48B 1.45B 62.26B 476M 427M 392M 355M 665M 45.22B 677M 4.68B 1.88B 23.79B 1.79B 1.75B 75.02B
Net income -94.65M -84.77M -77.97M -70.65M -132M -8.99B -135M -930M -373M -4.73B -355M -348M -14.91B -62.92M -56.35M -51.83M -46.96M -87.79M -5.97B -89.43M -618M -248M -3.14B -236M -231M -9.91B
Net Debt -126M -113M -104M -94.07M -176M -11.97B -179M -1.24B -497M -6.29B -473M -463M -19.85B -125M -112M -103M -93.08M -174M -11.84B -177M -1.23B -492M -6.23B -468M -458M -19.64B
Projected Income Statement - Annual - PROCEPT BioRobotics Corporation
Logo PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.
Employees
888
Date Price Change Volume
30/10/26 US$19.20 -5.42% 856,458
29/10/26 US$20.30 +0.50% 704,538
28/10/26 US$20.20 +2.02% 904,805
27/10/26 US$19.80 -0.15% 709,304
26/10/26 US$19.83 -0.65% 701,730
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - PROCEPT BioRobotics Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
19.20USD
Average target price
22.25USD
Spread / Average Target
+15.89%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PROCEPT BioRobotics Corporation
  1. Stock Market
  2. Stocks
  3. PRCT Stock